INT75484
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
In contrast to ALK5 signaling, TGF-? | |||||||||||||||
| |||||||||||||||
|
RI/ALK5 pathway and ALK5 inhibition prevents radiation-induced suppression of migration and sprouting | |||||||||||||||
| |||||||||||||||
|
1 in quiescent adult vasculature, ECs and mesenchymal cells were cocultured in Transwell or 3-D Matrigel in the presence of the ALK5 inhibitor SB-431542. | |||||||||||||||
| |||||||||||||||
|
Radiation also induced expression of PAI-1 mRNA, an ALK5 target gene, which was inhibited by the small molecular ALK5 inhibitor SB431542 (Figure 8b). | |||||||||||||||
| |||||||||||||||
|
Fibroblast cell lines from Tgfbr1 knock-in mouse | |||||||||||||||
| |||||||||||||||
|
is reduced - and this is associated with a loss in ALK5 expression, and TGF? | |||||||||||||||
| |||||||||||||||
|
Blocking ALK5 expression using siRNA resulted in elevated expression of MMP-13 [85]. | |||||||||||||||
| |||||||||||||||
|
Moreover, in two experimental models of OA - the DMM (meniscus destabilization) model and STR/ORT mice (spontaneous OA) - development of the disease was correlated with a loss of ALK5 expression. | |||||||||||||||
| |||||||||||||||
|
A prevailing expression of ALK5 will result in a dominance of the Smad2/3 signaling route, while ALK1 dominance will result in a stronger Smad1/5/8 pathway. | |||||||||||||||
| |||||||||||||||
|
on chondrocytes will be determined by the relative expression of ALK5 and ALK1. | |||||||||||||||
| |||||||||||||||
|
We postulate that the loss of ALK5 expression and the concomitant elevated ratio of ALK1/ALK5 will have profound effects on chondrocyte behavior. | |||||||||||||||
| |||||||||||||||
|
As a result, the ratio of ALK1/ALK5 expressing cells strongly increased in OA articular chondrocytes. | |||||||||||||||
| |||||||||||||||
|
In addition, overexpression of constitutive active ALK5 (Smad2/3) results in increased expression of aggrecan while constitutive ALK1 (Smad1/5/8) expression leads to elevated expression of MMP-13. | |||||||||||||||
| |||||||||||||||
|
In old animals, showing a decrease in the ALK5/ALK1 ratio, the protective effect of TGF? | |||||||||||||||
| |||||||||||||||
|
The ALK1 (Smad1/5/8) and ALK5 (Smad3) signaling balance in chondrocytes apparently determines MMP-13 expression. | |||||||||||||||
| |||||||||||||||
|
In this study, the expression of TGFbeta1 and its receptors, TbetaRI and TbetaRII, is examined in 21 cases of PDC by immunohistochemistry using specific antibodies, and the results are compared with those for 13 cases of CP. | |||||||||||||||
| |||||||||||||||
|
In the epithelial cells of PDC and CP, there are no significant differences in the expression of TGFbeta1, TbetaRI, and TbetaRII. | |||||||||||||||
| |||||||||||||||
|
Notably, signaling via ALK5 (Smad2/3 route) results in markedly different chondrocyte responses than ALK1 signaling (Smad1/5/8), and we postulate that the balance between ALK5 and ALK1 expression on chondrocytes will determine the overall effect of TGF? | |||||||||||||||
| |||||||||||||||
|
with ALK5i or TGF-? | |||||||||||||||
| |||||||||||||||
|
receptors, which have been investigated most thoroughly, are ubiquitously expressed ALK-5 and endothel-specific ALK-1. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.